2007 NSTI Nanotechnology Conference and Trade Show - Nanotech 2007 - 10th Annual

Arrogene, Inc

L. Foster
Arrogene, Inc, US

Pharma & Biotech

Arrogene has developed a cancer drug, Polycefin, with proven effectiveness in vivo and universal drug delivery device Polycefin with the ability to carry multiple drugs against several tumor biomarkers simultaneously. Polycefin penetrates the BBB and BTB and holds the promise of treating various forms of cancer and neurodegenerative disorders.

Back to Program

Sessions Sunday Monday Tuesday Wednesday Thursday Authors Keywords

Nanotech 2007 Conference Program Abstract


Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.